Literature DB >> 5392628

Gammahydroxybutyric acid.

M D Vickers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5392628     DOI: 10.1097/00004311-196900710-00007

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN: 0020-5907


× No keyword cloud information.
  8 in total

Review 1.  An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway.

Authors:  E E Kaufman; T Nelson
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

2.  Sodium oxybate: a potential new pharmacological option for the treatment of fibromyalgia syndrome.

Authors:  Todd J Swick
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

Review 3.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

4.  Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation.

Authors:  Julie Vienne; Bernhard Bettler; Paul Franken; Mehdi Tafti
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

5.  Gamma hydroxybutyrate--a coma inducing recreational drug.

Authors:  J M Ryan; I Stell
Journal:  J Accid Emerg Med       Date:  1997-07

6.  Gammahydroxy butyric acid: cardiovascular effects in the rat.

Authors:  C Gomes; C Flygt; M Henning; L Norin; T H Svensson; G Trolin
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

Review 7.  Behavioral analyses of GHB: receptor mechanisms.

Authors:  Lawrence P Carter; Wouter Koek; Charles P France
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

8.  A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.

Authors:  Charles F P George; Neil Feldman; Yanping Zheng; Teresa L Steininger; Susanna M Grzeschik; Chinglin Lai; Neil Inhaber
Journal:  Sleep Breath       Date:  2010-01-18       Impact factor: 2.816

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.